Association of L55M and Q192R Polymorphisms of Paraoxonase-1 Gene with Preeclampsia

Archives of Medical Research

Volumn 42, Issue 4, 2011, Pages 324-328

  Yaghmaei, Minoo ^a   Hashemi, Mohammad ^b,c   Azarian, Azin ^a   Moazeni Roodi, Abdolkarim ^d   Mokhtari, Mojgan ^a   Naghavai, Anoosh ^b   Salimi, Saeideh ^b   Mohammadi, Mahdi ^e   Taheri, Mohsen ^b   Ghavami, Saeid ^f  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Paraoxonase; Polymorphism; Preeclampsia

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; ARYLESTERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALLELE; ARTICLE; BIRTH WEIGHT; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVITY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREGNANT WOMAN; PRIMIGRAVIDA; PROTEIN BLOOD LEVEL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SPECTROPHOTOMETRY; SYSTOLIC BLOOD PRESSURE;

ARYLDIALKYLPHOSPHATASE; CARBOXYLIC ESTER HYDROLASES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS;

EID: 79961099578     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2011.06.006     Document Type: Article

References (32)

1. Roberts J.M., Cooper D.W. Pathogenesis and genetics of pre-eclampsia. Lancet 2001, 357:53-56.
2. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002, 77:67-75. ACOG practice bulletin.
3. Siddiqui I.A., Jaleel A., Tamimi W., et al. Role of oxidative stress in the pathogenesis of preeclampsia. Arch Gynecol Obstet 2010, 282:469-474.
4. Hubel C.A. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 1999, 222:222-235.
5. Zavalza-Gomez A.B. Obesity and oxidative stress: a direct link to preeclampsia?. Arch Gynecol Obstet 2011, 283:415-422.
6. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?. Lancet 1994, 344:721-724.
7. Gambhir J.K., Lali P., Jain A.K. Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis. Clin Biochem 1997, 30:351-355.
8. PrimoParmo S.L., Sorenson R.C., Teiber J., et al. The human serum paraoxonase arylesterase gene (PON1) is one member of a multigene family. Genomics 1996, 33:498-507.
9. Mackness M.I., Mackness B., Durrington P.N., et al. Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol 1996, 7:69-76.
10. Aviram M., Rosenblat M., Bisgaier C.L., et al. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 1998, 101:1581-1590.
11. Blatter M.C., James R.W., Messmer S., et al. Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase. Eur J Biochem 1993, 211:871-879.
12. Humbert R., Adler D.A., Disteche C.M., et al. The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet 1993, 3:73-76.
13. Garin M.C., James R.W., Dussoix P., et al. Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest 1997, 99:62-66.
14. Aviram M., Hardak E., Vaya J., et al. Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. Circulation 2000, 101:2510-2517.
15. Mackness B., Mackness M.I., Arrol S., et al. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. Febs Lett 1998, 423:57-60.
16. Kim Y.J., Park H., Lee H.Y., et al. Paraoxonase gene polymorphism, serum lipid, and oxidized low-density lipoprotein in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2007, 133:47-52.
17. Baker A.M., Klein R.L., Haeri S., et al. Association of midgestational paraoxonase 1 activity with pregnancies complicated by preeclampsia. Am J Perinatol 2010, 27:205-210.
18. Uzun H., Benian A., Madazli R., et al. Circulating oxidized low-density lipoprotein and paraoxonase activity in preeclampsia. Gynecol Obst Invest 2005, 60:195-200.
19. Sarandol E., Safak O., Dirican M., et al. Oxidizability of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in preeclampsia. Clin Biochem 2004, 37:990-996.
20. Kumru S., Aydin S., Gursu M.F., et al. Changes of serum paraoxonase (an HDL-cholesterol-associated lipophilic antioxidant) and arylesterase activities in severe preeclamptic women. Eur J Obstet Gynecol Reprod Biol 2004, 114:177-181.
21. Hashemi M., Moazeni-Roodi A.K., Fazaeli A., et al. Lack of association between paraoxonase-1 Q192R polymorphism and rheumatoid arthritis in southeast Iran. Genet Mol Res 2010, 9:333-339.
22. Hashemi M., Moazeni-Roodi A.K., Fazaeli A., et al. The L55M polymorphism of paraoxonase-1 is a risk factor for rheumatoid arthritis. Genet Mol Res 2010, 9:1735-1741.
23. Naderi M., Hashemi M., Komijani-Bozchaloei F., et al. Serum paraoxonase and arylesterase activities in patients with pulmonary tuberculosis. Pathophysiology 2011, 18:117-120.
24. Hashemi M., Kordi-Tamandani D.M., Sharifi N., et al. Paraoxonase and arylesterase activities in metabolic syndrome in Zahedan, southeast Iran. Eur J Endocrinol 2011, 164:219-222.
25. Feingold K.R., Memon R.A., Moser A.H., et al. Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response. Atherosclerosis 1998, 139:307-315.
26. Miesel R., Murphy M.P., Kroger H. Enhanced mitochondrial radical production in patients which rheumatoid arthritis correlates with elevated levels of tumor necrosis factor alpha in plasma. Free Radic Res 1996, 25:161-169.
27. Popa C., van Tits L.J., Barrera P., et al. Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients. Ann Rheum Dis 2009, 68:868-872.
28. Shih D.M., Gu L., Xia Y.R., et al. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 1998, 394:284-287.
29. Wang Y., Walsh S.W., Kay H.H. Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with preeclampsia. Am J Obstet Gynecol 1992, 167:946-949.
30. Wang Y.P., Walsh S.W., Guo J.D., et al. The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood. Am J Obstet Gynecol 1991, 165:1695-1700.
31. Gamboa R., Zamora J., Rodriguez-Perez J.M., et al. Distribution of paraoxonase PON1 gene polymorphisms in Mexican populations. Its role in the lipid profile. Exp Mol Pathol 2006, 80:85-90.
32. Isbilen E., Yilmaz H., Arzu Ergen H., et al. Association of paraoxonase 55 and 192 gene polymorphisms on serum homocysteine concentrations in preeclampsia. Folia Biol (Praha) 2009, 55:35-40.